切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - NPFF receptor - Voltage-gated Sodium (NaV) Channels - Squalene epoxidases - Adenosine A2A Receptors

20件产品中的 1-10

页面
每页
清除全部
  1. Regadenoson
    B5904 Regadenoson
     1 Citation
    中文名: 类伽腺苷
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体激动剂
      ≥18.05 mg/mL
      insoluble in H2O
  2. BIBP 3226 trifluoroacetate
    B7155 BIBP 3226 trifluoroacetate
    Target: NPY Receptors|NPFF receptor
    Summary: 混合NPY Y1和NPFF受体拮抗剂
      ≥78 mg/mL
      ≥12.13 mg/mL
  3. SCH 58261
    B6995 SCH 58261
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体竞争性拮抗剂
      ≥34.5 mg/mL
      insoluble in H2O
  4. ProTx II
    B5515 ProTx II
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.7通道阻断剂
      Soluble to 1 mg/mL
  5. Quinidine
    B7590 Quinidine
    中文名: 奎尼丁
    Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)
    Summary: 降低Na+和K+通道电流
      ≥11.95 mg/mL
      insoluble in H2O
  6. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  7. Bupivacaine HCl
    B1420 Bupivacaine HCl
    中文名: 盐酸布比卡因
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 麻醉药
      ≥10.25 mg/mL
      ≥16.23 mg/mL
  8. Phenytoin sodium
    B2272 Phenytoin sodium
    中文名: 苯妥英钠
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 钠通道稳定剂
      ≥11.55 mg/mL
      insoluble in H2O
  9. Proparacaine HCl
    B2274 Proparacaine HCl
    中文名: 盐酸丙美卡因
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 电压门控钠通道拮抗剂
      ≥14.9 mg/mL
      ≥17.73 mg/mL
  10. Butenafine HCl
    B1901 Butenafine HCl
    中文名: 盐酸布替萘芬
    Target: Squalene epoxidases
    Summary: 合成苄胺抗真菌剂
      ≥17.55 mg/mL
      insoluble in H2O

20件产品中的 1-10

页面
每页